The CSL share price has hit $300. Can it go higher?

The CSL Limited (ASX: CSL) share price has hit $300 a share for the first time ever. How much further can this ASX darling climb?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Well, it's finally happened. The CSL Limited (ASX: CSL) share price has hit $300 per share for the first time – which is both a new 52-week high and an all-time high. CSL shares opened at $299.94 this morning after closing at $297.26 yesterday, but quickly blew past the $300 per share mark jut after trading started, printing a new high watermark of $300.58.

The CSL share price has since pulled back slightly and is going for $298.95 at the time of writing.

Why are CSL shares at an all-time high?

Well, in large part it has to do with general positive momentum in the overall markets. Accompanying CSL's new high today has been a new high for the S&P/ASX 200 Index (INDEXASX: XJO), which has crossed the 7,000-point threshold for the very first time today as well.

News that US President Donald Trump has signed off on a 'Phase One' trade deal with China has been driving the positivity in the markets today, potentially signalling there is an end in sight to the now years-old trade war.

Nevertheless, this mornings high for CSL caps off a remarkable few years for the company's share price. It was only in December 2018 that CSL shares were going for under $180, which means that today's share price represents close to a 70% gain in just over 12 months.

Anyone who has held CSL shares for the past 5 years would be looking at roughly a 241% gain in that time (not including dividend returns).

Where to next for the CSL share price?

Quite frankly, that's anyone's guess. With a price-to-earnings (P/E) ratio of 48.92 on the current share price, it's starting to become tempting to label the valuation as stretched – to say the least. Remember this is a company that reported revenue growth of 11% last year and profit growth of 17%.

Those are good numbers, don't get me wrong. But do they justify a P/E ratio of close to 50?

The market seems to think so, but I'm not so sure. CSL has benefitted enormously in the last few years by a falling Australian dollar and a tight market for some of its most valuable blood/plasma medicines and products.

If these external tailwinds reverse in the next few years, I estimate it will lead to increasing pressure on CSL's revenue and earnings. And who knows what price the market will be willing to pay for each dollar of CSL's earnings then.

Foolish takeaway

CSL has always been a company that commands a premium price – and for good reason. But today's new highs are not getting me excited about adding this company to my own portfolio (despite how much I would like to).

Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »